FLUTICASONE PROPIONATE
Details
- Status
- Prescription
- First Approved
- 2004-05-14
- Routes
- TOPICAL, NASAL
- Dosage Forms
- CREAM, OINTMENT, SPRAY, METERED, LOTION
Companies
FLUTICASONE PROPIONATE Approval History
What FLUTICASONE PROPIONATE Treats
5 indicationsFLUTICASONE PROPIONATE is approved for 5 conditions since its original approval in 2004. These indications span multiple therapeutic areas including oncology, immunology, and more.
- Hay Fever
- Nasal Congestion
- Itchy Nose
- Runny Nose
- Sneezing
Drugs Similar to FLUTICASONE PROPIONATE
FDA-approved drugs for similar conditions. Compare mechanisms and indications to understand treatment alternatives.
Active Pipeline
Ongoing clinical trials by development phase
Key Completed Trials
Completed studies with published results, ranked by significance
Trial Timeline
Full development history with FDA approval milestones
Understanding FDA Approval Types
| Count | Type | What it means |
|---|---|---|
| - | ORIG | Original approval - drug first enters market |
| - | SUPPL - Efficacy | New indication (new disease/condition approved) |
| - | SUPPL - Labeling | Label text changes (warnings, dosing updates) |
| - | SUPPL - Manufacturing | Production changes (new facility) |
| - | SUPPL - Chemistry | Formulation changes (new dosage strength) |
Green lines in the timeline show ORIG and Efficacy approvals - the clinically meaningful milestones.
FLUTICASONE PROPIONATE FDA Label Details
ProIndications & Usage
Uses Temporarily relieves these symptoms of hay fever or other upper respiratory allergies: nasal congestion itchy, watery eyes itchy nose runny nose sneezing
Want competitive intelligence?
See who's developing similar drugs and track their progress
Data Sources
Data sourced from official FDA and NIH databases. Click links to verify on original sources.